- Partner & SPARK Team
We want to thank you for an eventful, exciting and successful SPARK year, and wish you a wonderful Christmas time and a good start into the new year. We would be extremely happy for your further support in 2017. You are warmly invited to attend our upcoming Educational Forum on "Women in Leadership and Pitching" by Ida Beerhalter. Also, please check out our new schedule for 2017, including our brand new entrepreneurial lecture series.
Application until January 10, 2017 - 3:00 PM via BIH Portal
The BIH Technology Transfer Fund is characterized by a straightforward application process with a high degree of flexibility in the allocation of funds. The funds are limited to a short period of use. They are to be used explicitly for the validation of the commercial potential. The fund therefore includes the possibility of awarding contracts for industrial-standard services to third parties whereas personnel costs shall be funded in exceptional cases only.
In addition to financial support, the BIH Technology Transfer Fund offers the possibility of professional advice as part of the expert assessment process. The external experts will contact all the applicants in person to discuss the project application in any given case and to comment on the submitted project plan. The applicants will therefore have the opportunity to discuss their projects in detail with the experts. This individual contact between applicants and assessors is a special and important element of the BIH Technology Transfer Fund. The fund offers the applicants in-depth professional advice regardless of whether the applications were selected for funding.
Applicants who are not granted funding are specifically asked to submit their revised project proposals when the next call for applications is published.
For more information visit:
Application until January 15th, 2017
High-Tech Grnderfonds organizes with the B. Braun-Stiftung a German-Benelux Life Science Pitch Day in Aachen.
On this day, life science startups looking for seed and Series A financing present in front of venture capitalists (such as Gilde Healthcare, Vesalius Biocapital, Creathor, and HTGF), corporates (such as Philips and B. Braun), family offices, and business angels. In addition, these startups will have the opportunity to learn from investors and entrepreneurs about the lessons learnt in running a company (dos and donts) in a startup workshop preceding the pitches.
The event is free of charge. If you want to secure a presentation slot, please apply by email to aachen2017(at)htgf.de no later than January 15th, 2017 and kindly include a non-confidential executive summary or presentation of your startup.
MERCK ACCELERATOR GERMANY SPRING 2017 APPLICATION IS NOW OPEN!
- You are: A startup in the fields of Healthcare, Life Science and Performance Materials
- Application: October 17, 2016 – December 19, 2016
- Announcement: February 15, 2017
- Program duration: March 6, 2017 – May 24, 2017
Are you ready to get your start-up to the next level?
The Merck Accelerator is looking for true innovators and entrepreneurs with a start-up mindset. Candidates applying to the accelerator program should be startups in the fields of healthcare, life science and performance materials who are dedicated to the program and ready to give their all for the entire program period.
You can now follow us on linkedin !
Also join our linkedin SPARK BERLIN GROUP to share information and ideas, network, and find resources within the local and global SPARK community!
FU Berlin: A cooperation between Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Humboldt University Berlin and Technical University Berlin will support start-ups on campus within the project "University Startup Factory”. The project is funded by the European Social Fund and the Senate Department for Economics, Technology and Research with about 855.000 Euro, which are disposable from August 2016 to December 2017 to support founders with technology-based ideas.
The core of the "University Startup Factory” are scholarships, each of 1,500 Euro/per month for a period of six months with an option to extend, which will be awarded to the members of selected start-up teams. The application is open to university graduates with a technology-based business concept and technical or complementary skills that are necessary to implement the start-up projects. The founding teams will be supervised by the respective university and will benefit from the close connection to research groups and to technical infrastructure. Further criteria for the scholarship are a full-time dedication to the start-up project and a residence in Berlin. The deadline of the first round of funding is the 18th of September 2016.
Application: until September 9
Areas of interest: Oncology and related technologies
"Pfizer is constantly exploring opportunities for partnerships and invites you to submit a research collaboration proposal for the 1st Pfizer Biotech Partnering Days on October 4–5, 2016 in Berlin.
Your non-confidential proposals will be reviewed by the respective Pfizer Research Teams and those fitting Pfizer’s research objectives will be invited to present their work and engage in discussion with Pfizer scientists. The event itself consists of two phases: a presentation of cutting-edge findings by innovation teams selected for the excellence of their work, as well as one-on-one meetings between the presenters and scientists from Pfizer focused on a specific field of research. This is an opportunity to highlight the excellence and expertise of European research to Pfizer and to support the competitiveness of Europe at a global level. Companies outside of Germany are also encouraged to submit research proposals."
We are proud to announce that one of our SPARK funded projects, the team of Felix Lorenz, Elisa Kieback, Julian Clauss and Inan Edes just won the highly competitive OneStart accelerator competition. In the laboratory of Prof. Wolfgang Uckert at the MDC in Berlin, the team of Captain T cell has developed a platform to identify T cell receptors for cancer immunotherapy. With this project they applied to OneStart the highly competitive and world’s largest life sciences and healthcare startup accelerator. They were chosen from 400 applicants to attend a week-long bootcamp in London. On May 16th they were announced the winning team.
If you want to find our more, please visit OneStart.
Captain T cell will also pitch at the Charité Entrepreneurship Summit on May 26th.